Ignite Creation Date:
2024-05-06 @ 1:16 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01775267
Status:
TERMINATED
Last Update Posted:
2015-06-09
First Post:
2013-01-22
Brief Title:
ALLPS VERSUS PVO Randomized Controlled Trial
Sponsor:
University of Zurich
Organization:
University of Zurich
Study Overview
Official Title:
ASSOCIATING LIVER PARTITION WITH PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY ALPPS Versus Conventional Portal Vein Occlusion PVO for Resection of Liver Tumors Unresectable in One Step - a Randomized Controlled Trial
Status:
TERMINATED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study stopped due to safety concerns in both study arms
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALPPS
Brief Summary:
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy ALPPS or portal vein occlusion PVO works in treating patients with liver cancer Both treatments are types of 2-stage hepatectomies for removing liver cancer ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable
Trial with surgical intervention
Trial with surgical intervention
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None